Estimation of QT interval prolongation through model-averaging

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Pharmacokinetics and Pharmacodynamics

• Publication date

  2017-04-18

• Fields of study

  Medicine, Mathematics

• Identifiers
  DOI 10.1007/s10928-017-9523-3PMID 28421417
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correction to: Scientific white paper on concentration-QTc modeling

  2018cited by this paper
• Bayesian model averaging method for evaluating associations between air pollution and respiratory mortality: a time-series study

  2016cited by this paper
• How robust are the estimated effects of air pollution on health? Accounting for model uncertainty using Bayesian model averaging

  2016cited by this paper
• Model averaging inconcentration–QT analyses

  2016cited by this paper
• Clinical QTc Assessment in Oncology

  2016cited by this paper
• Model Selection And Model Averaging

  2016cited by this paper
• Estimating the Probability of Rare Events Occurring Using a Local Model Averaging

  2016cited by this paper
• Viewpoint: model selection uncertainty, pre‐specification, and model averaging

  2015cited by this paper
• Phase I trial design for drug combinations with Bayesian model averaging

  2015cited by this paper
• Linear mixed‐effects model of QTc prolongation for olmesartan medoxomil

  2015cited by this paper
• Model selection versus model averaging in dose finding studies

  2015cited by this paper
• Detection of QTc Effects in Small Studies—Implications for Replacing the Thorough QT Study

  2015cited by this paper
• Utility of concentration‐effect modeling and simulation in a thorough QT study of losmapimod

  2015cited by this paper
• Weighted Score Tests Implementing Model-Averaging Schemes in Detection of Rare Variants in Case-Control Studies

  2015cited by this paper
• Challenges and Innovations in Pharmaceutical Products Development

  2015cited by this paper
• A Hierarchical Bayesian Model Averaging Framework for Groundwater Prediction under Uncertainty

  2015cited by this paper
• Evaluating the Use of Linear Mixed-Effect Models for Inference of the Concentration-QTc Slope Estimate as a Surrogate for a Biological QTc Model

  2015cited by this paper
• Incorporating exposure‐response modeling into the assessment of QTc interval: A potential alternative to the thorough QT study

  2015cited by this paper
• Tafenoquine at therapeutic concentrations does not prolong fridericia-corrected QT interval in healthy subjects

  2014cited by this paper
• Model averaging for genome-enabled prediction with reproducing kernel Hilbert spaces: a case study with pig litter size and wheat yield.

  2014cited by this paper
• The IQ‐CSRC Prospective Clinical Phase 1 Study: “Can Early QT Assessment Using Exposure Response Analysis Replace the Thorough QT Study?”

  2014cited by this paper
• Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol.

  2014cited by this paper
• Dose-finding studies, MCP-Mod, model selection, and model averaging: Two applications in the real world

  2014cited by this paper
• Use Of Model Averaging Techniques in Cost-Effectiveness Analysis in Oncology.

  2014cited by this paper
• The effects of active metabolites on parameter estimation in linear mixed effect models of concentration–QT analyses

  2013cited by this paper
• The Stream Algorithm: Computationally Efficient Ridge-Regression via Bayesian Model Averaging, and Applications to Pharmacogenomic Prediction of Cancer Cell Line Sensitivity

  2013cited by this paper
• Early QT assessment – how can our confidence in the data be improved?

  2013cited by this paper
• Reconstruction of Large-Scale Gene Regulatory Networks Using Bayesian Model Averaging

  2012cited by this paper
• Delayed Effects in the Exposure-Response Analysis of Clinical QTc Trials

  2012cited by this paper
• Enhanced Sensitivity to Drug‐Induced QT Interval Lengthening in Patients With Heart Failure Due to Left Ventricular Systolic Dysfunction

  2012cited by this paper
• Moxifloxacin versus placebo modeling of the QT interval

  2012cited by this paper
• A Bayesian Model Averaging Approach for Estimating the Relative Risk of Mortality Associated with Heat Waves in 105 U.S. Cities

  2011cited by this paper
• Design, Conduct and Analysis of Thorough QT Studies

  2011cited by this paper
• Comparison of QTc Data Analysis Methods Recommended by the ICH E14 Guidance and Exposure–Response Analysis: Case Study of a Thorough QT Study of Asenapine

  2011cited by this paper
• Population Pharmacokinetic and Concentration—QTc Models for Moxifloxacin: Pooled Analysis of 20 Thorough QT Studies

  2011cited by this paper
• Effects of Standard and Supratherapeutic Doses of Nelfinavir on Cardiac Repolarization: A Thorough QT Study

  2009cited by this paper
• A Perspective on the Use of Concentration‐QT Modeling in Drug Development

  2008cited by this paper
• A Bayesian model averaging approach with non‐informative priors for cost‐effectiveness analyses

  2008cited by this paper
• Statistical Issues of QT Prolongation Assessment Based on Linear Concentration Modeling

  2008cited by this paper
• Concentration‐QT Relationships Play a Key Role in the Evaluation of Proarrhythmic Risk During Regulatory Review

  2008cited by this paper
• Pharmacokinetics and Safety of Ketorolac Following Single Intranasal and Intramuscular Administration in Healthy Volunteers

  2007cited by this paper
• Pharmacokinetic-Pharmacodynamic Modeling And Simulation

  2005cited by this paper
• Applied Longitudinal Analysis

  2004cited by this paper
• Model selection and multimodel inference : a practical information-theoretic approach

  2003cited by this paper
• Linear Mixed Models for Longitudinal Data

  2001cited by this paper
• The Little Bootstrap and other Methods for Dimensionality Selection in Regression: X-Fixed Prediction Error

  1992cited by this paper
• Empirical Model‐Building and Response Surfaces

  1988cited by this paper

• No citing papers are available for this paper.